[非hiv患者感染新型冠状病毒感染后的肺囊虫肺炎]。

Pub Date : 2022-06-01 DOI:10.4067/s0716-10182022000200357

María Amparo-Vicente, Elena Morte

{"title":"[非hiv患者感染新型冠状病毒感染后的肺囊虫肺炎]。","authors":"María Amparo-Vicente, Elena Morte","doi":"10.4067/s0716-10182022000200357","DOIUrl":null,"url":null,"abstract":"Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].\",\"authors\":\"María Amparo-Vicente, Elena Morte\",\"doi\":\"10.4067/s0716-10182022000200357\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4067/s0716-10182022000200357\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4067/s0716-10182022000200357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

由SARS-CoV-2引起的严重呼吸道感染患者感染耶氏肺囊虫是我们今天必须考虑的情况。皮质疗法和其他危险因素使其易感。这是一个诊断挑战，治疗后，预后良好。我们报告一例因SARS-CoV-2感染而患严重肺炎的男性患者，他接受了皮质类固醇治疗，后来因P. jroveci感染而患肺炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].

Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助